University:
West Coast University
Course:
PHAR 835 | IPC Neurology/Psychiatry
Academic year:

2024
Views:

398

Pages:

2
Author:

Asal A.

QUESTION 2 A newly alzheimer's disease patient was diagnosed with MMISE of 21. She feels she keep losing her lays, what would be an appropriats recommendation? Initiate Donepezil 5 mg daila B. Initiate Memantine 5 mg daily for a week and bitrate up to a target dose of 10 mg twice daily if tolerated C. Initiate Memantine/donepezil 7mg/10mg daily D. Don't treat patient at this stage QUESTION 3 hypersens APIA MRI Which of the statements below are true regarding Aduhelm? Selesal Alops Lagng that apply. A. Aduhelm may be given once weekly onally or once monthly intravenously B. Aduhelm was approved by the FDA under accelerated approval based on reduction in amyloid beta plaques while on therapy yoor C. Patients receiving intravenous therapy should have a prior to the 7th and 12th infusions brain MR within one month prior to starting therapy as well as just D. Angioedema and hypersensitivity reactions have occurred and should be monitored for with each administration, stopping therapy if they occur An 82 year old male with mild Alzheimers dementia has had a some worsening symptoms of memory loss. He has a past history of Mi Raynauds disceder, and kidney disease Vitals at the clinic before intiation therapy Vitals at home after therapy initiation BP 138/72 BP 110/65 Pulse 54 Pulse 45 Current medications include: Aspirin 81 mg daily Diltiazem 240 mg once daily Ranitidine 150 mg as needed for heartburn • Lisinopril 5 mg daily Donepezil 10 mg once daily is initiated. Following initiation, he did not report any Gi complaints but the family did notice increased lethargy and extreme fatigue. What is the reason for this new symptom and how to address it? A. Patient is having hypotension D/c Dilitiazem B. Patient is having Bradycardia D/c Dillazem C. Patient is having Bradycardia, reduce dose of Aricept to 5mg QUESTION 1 MOLA, MNSE (SLC/MS To assess Alzheimer's disease a neurologist can use this assessment tool: A. Montreal cognitive assessment (MOCA) B. Hoehn and Yahr C. UPDRS D. Brief Psychiatric Rating Scale (BPRS)